Developing a novel method for assessing global genetic diversity and molecular surveillance of Mycoplasma pneumoniae during its re-emergence after the COVID-19 pandemic and beyond

Institutions involved: Cardiff Metropolitan University, University Children's Hospital Zurich, University of Oxford, University of Lisbon, Lausanne University Hospital

Supported by ESGMAC, ESGEM and ESGMD (2024-2026) study groups from the ESCMID

Our project, supported by ESGMD, ESGMAC and ESGEM, aims to develop a novel culture-independent whole-genome sequencing method for characterizing the population structure of Mycoplasma pneumoniae during its re-emergence in late 2023.